Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy.
Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puéchal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X; RATIO (Research Axed on Tolerance of Biotherapies) Study Group. Sellam J, et al. Among authors: breban m. Ann Rheum Dis. 2007 Dec;66(12):1610-5. doi: 10.1136/ard.2007.069799. Epub 2007 Apr 24. Ann Rheum Dis. 2007. PMID: 17456528 Free PMC article.
TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology.
Pham T, Guillemin F, Claudepierre P, Luc M, Miceli-Richard C, Fautrel B, de Bandt M, Breban M, Goupille P, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B; Club Rhumatismes et Inflammation (CRI); Société Française de Rhumatologie (SFR). Pham T, et al. Among authors: breban m. Joint Bone Spine. 2006 Oct;73(5):547-53. doi: 10.1016/j.jbspin.2006.02.005. Epub 2006 Jun 30. Joint Bone Spine. 2006. PMID: 16843030
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H, Mariette X, Godot V, Weldingh K, Hamid AM, Prejean MV, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Delchier JC, Flipo RM, Dautzenberg B, Salmon D, Humbert M, Emilie D; RATIO (Recherche sur Anti-TNF et Infections Opportunistes) Study Group. Hamdi H, et al. Among authors: breban m. Arthritis Res Ther. 2006;8(4):R114. doi: 10.1186/ar1994. Arthritis Res Ther. 2006. PMID: 16859506 Free PMC article.
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update.
Pham T, Fautrel B, Dernis E, Goupille P, Guillemin F, Le Loët X, Ravaud P, Claudepierre P, Miceli-Richard C, de Bandt M, Breban M, Maillefert JF, Masson C, Saraux A, Schaeverbeke T, Wendling D, Mariette X, Combe B; Club Rhumatismes et Inflammation (CRI/SFR). Pham T, et al. Among authors: breban m. Joint Bone Spine. 2007 Dec;74(6):638-46. doi: 10.1016/j.jbspin.2007.10.003. Epub 2007 Nov 8. Joint Bone Spine. 2007. PMID: 18065252
Maintenance of infliximab treatment in ankylosing spondylitis: results of a one-year randomized controlled trial comparing systematic versus on-demand treatment.
Breban M, Ravaud P, Claudepierre P, Baron G, Henry YD, Hudry C, Euller-Ziegler L, Pham T, Solau-Gervais E, Chary-Valckenaere I, Marcelli C, Perdriger A, Le Loët X, Wendling D, Fautrel B, Fournié B, Combe B, Gaudin P, Jousse S, Mariette X, Baleydier A, Trape G, Dougados M; French Ankylosing Spondylitis Infliximab Network. Breban M, et al. Arthritis Rheum. 2008 Jan;58(1):88-97. doi: 10.1002/art.23167. Arthritis Rheum. 2008. PMID: 18163509 Free article. Clinical Trial.
Circulating concentration of infliximab and response to treatment in ankylosing spondylitis: results from a randomized control study.
Krzysiek R, Breban M, Ravaud P, Prejean MV, Wijdenes J, Roy C, Henry YD, Barbey C, Trappe G, Dougados M, Emilie D; French Ankylosing Spondylitis Infliximab Network. Krzysiek R, et al. Among authors: breban m. Arthritis Rheum. 2009 May 15;61(5):569-76. doi: 10.1002/art.24275. Arthritis Rheum. 2009. PMID: 19405015 Free article. Clinical Trial.
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X; Research Axed on Tolerance of Biotherapies Group. Tubach F, et al. Among authors: breban m. Arthritis Rheum. 2009 Jul;60(7):1884-94. doi: 10.1002/art.24632. Arthritis Rheum. 2009. PMID: 19565495 Free PMC article.
249 results